TILRAY BRANDS INC (TLRY) Stock Price, Forecast & Analysis

NASDAQ:TLRY • US88688T2096

7.55 USD
-0.2 (-2.58%)
At close: Feb 23, 2026
7.5754 USD
+0.03 (+0.34%)
After Hours: 2/23/2026, 8:18:29 PM

TLRY Key Statistics, Chart & Performance

Key Statistics
Market Cap879.65M
Revenue(TTM)837.32M
Net Income(TTM)-2.11B
Shares116.51M
Float115.59M
52 Week High23.2
52 Week Low3.51
Yearly DividendN/A
Dividend Yield0%
EPS(TTM)-14.37
PEN/A
Fwd PEN/A
Earnings (Next)04-06
IPO2018-07-19
Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals
TLRY short term performance overview.The bars show the price performance of TLRY in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -10 -20 -30 -40

TLRY long term performance overview.The bars show the price performance of TLRY in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 -20 -40 -60

The current stock price of TLRY is 7.55 USD. In the past month the price decreased by -16.57%. In the past year, price increased by 2.72%.

TILRAY BRANDS INC / TLRY Daily stock chart

TLRY Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating
TLRY Full Technical Analysis Report

TLRY Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to TLRY. TLRY may be in some trouble as it scores bad on both profitability and health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
TLRY Full Fundamental Analysis Report

TLRY Financial Highlights

Over the last trailing twelve months TLRY reported a non-GAAP Earnings per Share(EPS) of -14.37. The EPS decreased by -379% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -100.42%
ROE -133.4%
Debt/Equity 0.18
Chartmill High Growth Momentum
EPS Q2Q%59%
Sales Q2Q%3.11%
EPS 1Y (TTM)-379%
Revenue 1Y (TTM)0.98%
TLRY financials

TLRY Forecast & Estimates

17 analysts have analysed TLRY and the average price target is 12.64 USD. This implies a price increase of 67.45% is expected in the next year compared to the current price of 7.55.

For the next year, analysts expect an EPS growth of 96.56% and a revenue growth 3.75% for TLRY


Analysts
Analysts70.59
Price Target12.64 (67.42%)
EPS Next Y96.56%
Revenue Next Year3.75%
TLRY Analyst EstimatesTLRY Analyst Ratings

TLRY Ownership

Ownership
Inst Owners11.21%
Ins Owners0.35%
Short Float %13.71%
Short Ratio1.46
TLRY Ownership

TLRY Competitors/Peers

The largest stocks on the US markets in the "Pharmaceuticals" sub-industry
Full List
SymbolCompany NameTechnical RatingFundamental RatingFPEMarket Cap
LLY ELI LILLY & CO31.54954.38B
JNJ JOHNSON & JOHNSON21.1584.231B
MRK MERCK & CO. INC.22.88303.452B
PFE PFIZER INC9.01151.524B
BMY BRISTOL-MYERS SQUIBB CO10.07123.489B
ZTS ZOETIS INC18.3256.752B
RPRX ROYALTY PHARMA PLC- CL A8.7726.045B
VTRS VIATRIS INC6.3118.336B
ELAN ELANCO ANIMAL HEALTH INC23.6712.412B
AXSM AXSOME THERAPEUTICS INC213.399.261B

About TLRY

Company Profile

TLRY logo image Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. The company is headquartered in Leamington, Ontario and currently employs 2,842 full-time employees. The company went IPO on 2018-07-19. The firm operates through four segments: Cannabis operations, Distribution business, Beverage alcohol business and Wellness business. The Cannabis operations, which encompasses the production, distribution, sale, co-manufacturing and advisory services of both medical and adult-use cannabis. The Beverage alcohol operations, which encompasses the production, marketing and sale of beverage alcohol products. The Distribution operations, which encompasses the purchase and resale of pharmaceuticals products to customers. The Wellness products, which encompasses hemp foods and cannabidiol (CBD) products. The firm offers a portfolio of adult-use brands and products and expands its portfolio to include new cannabis products and formats. Its brands include Good Supply, RIFF, Broken Coast, Solei, Canaca, HEXO, Redecan, Original Stash, Hop Valley, Revolver, Bake Sale, XMG, Mollo, and others.

Company Info

TILRAY BRANDS INC

265 Talbot Street West

Leamington ONTARIO V9X 1J2 CA

CEO: Irwin D. Simon

Employees: 2842

TLRY Company Website

TLRY Investor Relations

Phone: 13026365400

TILRAY BRANDS INC / TLRY FAQ

Can you describe the business of TILRAY BRANDS INC?

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. The company is headquartered in Leamington, Ontario and currently employs 2,842 full-time employees. The company went IPO on 2018-07-19. The firm operates through four segments: Cannabis operations, Distribution business, Beverage alcohol business and Wellness business. The Cannabis operations, which encompasses the production, distribution, sale, co-manufacturing and advisory services of both medical and adult-use cannabis. The Beverage alcohol operations, which encompasses the production, marketing and sale of beverage alcohol products. The Distribution operations, which encompasses the purchase and resale of pharmaceuticals products to customers. The Wellness products, which encompasses hemp foods and cannabidiol (CBD) products. The firm offers a portfolio of adult-use brands and products and expands its portfolio to include new cannabis products and formats. Its brands include Good Supply, RIFF, Broken Coast, Solei, Canaca, HEXO, Redecan, Original Stash, Hop Valley, Revolver, Bake Sale, XMG, Mollo, and others.


What is the current price of TLRY stock?

The current stock price of TLRY is 7.55 USD. The price decreased by -2.58% in the last trading session.


Does TILRAY BRANDS INC pay dividends?

TLRY does not pay a dividend.


How is the ChartMill rating for TILRAY BRANDS INC?

TLRY has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.


What is the analyst forecast for TLRY stock?

17 analysts have analysed TLRY and the average price target is 12.64 USD. This implies a price increase of 67.45% is expected in the next year compared to the current price of 7.55.


Can you provide the sector and industry classification for TILRAY BRANDS INC?

TILRAY BRANDS INC (TLRY) operates in the Health Care sector and the Pharmaceuticals industry.